subfoveal choroidal thickness before and after intravitreal Ranibizumab injection in patients with choroidal neovascularization
Background: Ranibizumab is anti-vascular endothelial growth factor (anti-VEGF) agent made for intraocular use, like smaller antibody fragment that can penetrate retina. Intravitreal ranibizumab therapy has been accepted as a predominant treatment for CNV in recent years. Objective: To assess potenti...
में बचाया:
| मुख्य लेखकों: | , , |
|---|---|
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Al-Azhar University, Faculty of Medicine
2023-01-01
|
| श्रृंखला: | Al-Azhar International Medical Journal |
| विषय: | |
| ऑनलाइन पहुंच: | https://aimj.journals.ekb.eg/article_473658_934df1eaa3fe56acb48118adb37229ab.pdf |
| टैग: |
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|